Cargando…
(13)[C]-Urea Breath Test as a Novel Point-of-Care Biomarker for Tuberculosis Treatment and Diagnosis
BACKGROUND: Pathogen-specific metabolic pathways may be detected by breath tests based on introduction of stable isotopically-labeled substrates and detection of labeled products in exhaled breath using portable infrared spectrometers. METHODOLOGY/PRINCIPAL FINDINGS: We tested whether mycobacterial...
Autores principales: | Jassal, Mandeep S., Nedeltchev, Gueno G., Lee, Jong-Hee, Choi, Seong Won, Atudorei, Viorel, Sharp, Zachary D., Deretic, Vojo, Timmins, Graham S., Bishai, William R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929202/ https://www.ncbi.nlm.nih.gov/pubmed/20805989 http://dx.doi.org/10.1371/journal.pone.0012451 |
Ejemplares similares
-
Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test
por: Choi, Seong Won, et al.
Publicado: (2014) -
A modified scoring system to describe gross pathology in the rabbit model of tuberculosis
por: Jassal, Mandeep S, et al.
Publicado: (2011) -
In Vitro and In Vivo Studies of a Rapid and Selective Breath Test for Tuberculosis Based upon Mycobacterial CO Dehydrogenase
por: Maiga, Mamoudou, et al.
Publicado: (2014) -
Rapamycin modulates pulmonary pathology in a murine model of Mycobacterium tuberculosis infection
por: Bhatt, Kamlesh, et al.
Publicado: (2021) -
Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory epithelial cells
por: Poschet, Jens F., et al.
Publicado: (2020)